14 Abr DREAM modulator compounds. A new approach for the treatment of neurodegenerative and auto-inflammatory diseases.
Posted at 11:52h
in transferencia
[one_fourth]
[/one_fourth][three_fourth_last][box]CSIC, CIBERNED and UAM have found a new family of phenylacetamide derivatives which act as modulators of the calcium neuronal sensor DREAM (Downstream Regulator Element Antagonist Modulator). Therefore, these compounds are useful for the treatment of pathologies associated to change in the DREAM activity, including neurodegenerative and autoinflammatory diseases, and sensory perception disorders.[/box]
Download Leaflet
[/three_fourth_last]